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Background: Global health equity strategists have previously focused much on differences across countries. At first
glance, the global health gap appears to result primarily from disparities between the developing and developed
regions. We examine how much of this disparity could be attributed to within-country disparities in developing
nations.
Methods: We used data from Demographic and Health Surveys conducted between 1995 and 2010 in 67
developing countries. Using a population attributable risk approach, we computed the proportion of global
under-five mortality gap and the absolute number of under-five deaths that would be reduced if the under-five mortality
rate in each of these 67 countries was lowered to the level of the top 10% economic group in each country. As a
sensitivity check, we also conducted comparable calculations using top 5% and the top 20% economic group.
Results: In 2007, approximately 6.6 million under-five deaths were observed in the 67 countries used in the analysis. This
could be reduced to only 600,000 deaths if these countries had the same under-five mortality rate as developed
countries. If the under-five mortality rate was lowered to the rate among the top 10% economic group in each of these
countries, under-five deaths would be reduced to 3.7 million. This corresponds to a 48% reduction in the global mortality
gap and 2.9 million under-five deaths averted. Using cutoff points of top 5% and top 20% economic groups showed
reduction of 37% and 56% respectively in the global mortality gap. With these cutoff points, respectively 2.3 and 3.4
million under-five deaths would be averted.
Conclusion: Under-five mortality disparities within developing countries account for roughly half of the global gap
between developed and developing countries. Thus, within-country inequities deserve as much consideration as do
inequalities between the world’s developing and developed regions.
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Increased attention has recently been given to economic
disparities in health status, health service coverage, and
their impact on health improvements in developing coun-
tries [1-5]. In these countries, children from poor families
have higher risk of death than those from rich families,
but paradoxically, rich families are generally the first to
take advantage of health interventions that are not ag-
gressively targeted to the poor [1,6,7]. Improvements in* Correspondence: aamouzou@jhsph.edu
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tries require special attention to addressing the health
equity gap between poor and rich within and across coun-
tries by ensuring that health programs incorporate strat-
egies addressing inequalities [2,3]. Recent studies have
demonstrated that countries that have reached high cover-
age of maternal, newborn, and child health interventions
are also those that showed reduced socio-economic in-
equalities in these coverage levels [4,5,8-10]. Other studies
have shown that strategies that focus on equity are cost-
effective compared to other mainstream approaches. Sev-
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elimination of user fees [9,10].
On the surface, calls for such a focus on health condi-
tions among the poor within developing countries in
order to reduce the global health gap might seem
strange. By some standard measures, inequalities be-
tween the world’s developed and developing regions are
far larger than intra-country disparities. Take the case of
under-five mortality rates (U5MR), or the number of
children dying between birth and age five per 1000 live
births. U5MR is the health status indicator for which the
greatest amount of relevant evidence is available and a
key indicator for the fourth Millennium Development
Goal of reducing U5MR by two-thirds between 1990
and 2015. A recent survey of 56 low- and middle-
income countries (LMIC) found that the U5MR within
the poorest 20% of a national population during the
1990s was, on average, almost twice as high as that in
the population’s best-off 20% [6]. At that time, the aver-
age U5MR in the same set of LMICs was over twelve
times as high as that in the developed world. Estimates
from the UN Interagency Group for Mortality Estima-
tion in 2012 indicate that U5MR in developing regions
was about nine times as high as that of the developed re-
gions. In terms of burden of under-five deaths, while
about 6.5 million deaths were estimated for developing
countries in 2012, only 90,000 deaths were estimated for
developed countries [11]. Seen in this light, the disparity
within the typical developing country does not seem
large enough to merit much concern in the formulation
of global health equity strategies, and an emphasis on re-
ducing disparities between developed and developing
countries at global level would be justified.
We argue in this paper that such conclusion would
be misguided without careful analysis of the magnitude of
intra- and inter-country disparities. Such an analysis
would examine each kind of disparity’s contribution to the
gap between developed and developing countries by ap-
plying a variant of the population attributable risk ap-
proach, widely used to estimate the reduction in mortality
brought about by eliminating a particular cause of death.
The purpose of our study is to determine how much
of the under-five mortality gap between developed and
developing countries can be reduced by improving mor-
tality rates of developing countries to the level of their
highest income groups. Although several studies, such as
the “Global Health 2035” Lancet Commission report,
[12] have recently drawn attention to health inequities,
no known study has attempted to quantify the size of
the inequity between developed and developing coun-
tries and the relative contribution of the inequality gap
within developing countries to the global inequality.
Such studies are necessary to provide evidence for health
inequality reduction programming.Our findings highlight the magnitude of mortality bur-
den attributable to within-country inequalities and cor-
roborate the need for focused priority policies toward




To estimate U5MR for different economic strata of de-
veloping country populations, we required data that 1)
include both information about mortality and socio-
economic status, and 2) are large enough to contain
information on under-five deaths that provide reliable
estimates on subgroups of the population. We selected
most recent Demographic and Health Surveys (DHS),
which meet the aforementioned criteria. We used the
wealth index as indicator of economic status. The wealth
index, a composite measure of a household economic
status, is derived from household assets and characteris-
tics using principal component analysis [13,14]. The
index is widely used to split the household population
into economic groups of different levels in order to
analyze economic inequalities. Data from before 1994
were excluded due to smaller sample sizes and limited
information on asset variables used for the wealth index
computation. For countries with multiple surveys, we
used only the most recent survey. A total number of 67
DHS datasets were retained (available as of December
2012) and included in the analysis, with a median year
of survey of 2007. These 67 DHS countries represent
83.8 million births, or approximately 70% of births in
LMICs in 2007. We defined developing countries as
those categorized as low- or middle-income countries by
the World Development Indicators published by the
World Bank (list of countries available in Additional
file 1: Table S1) [15].
Analysis
Data on under-five mortality in the highest economic
groups needed for the estimation of the intra-country
mortality gap was derived by pooling all country datasets
on interviewed women’s birth histories. Prior to pooling
those datasets, the wealth index already available in each
DHS dataset, was used to split the household population
into groups of equal size. The principal focus was on the
top 10% (decile) of the sample population; as sensitivity
checks, we also selected the top 5% (ventile) and 20%
(quintile) of the sampled population. The pooled dataset
was used to compute U5MR for the top decile, ventile,
and quintile of the total population of the 67 countries,
using appropriate adjustment weights. The wealth quin-
tile variable (five subgroups of the household population
based on the wealth score) was already available in each
country dataset. The pooled U5MR was weighted such
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weighted average of the 67 country-specific U5MRs, with
weights representing the proportion of country births in
the total number of births. The final weights used in the
pooled dataset combined these latter weights with sam-
pling weights provided in each dataset. We computed the
U5MR using life table approach with a synthetic cohort
approach [16].
Application of the population attributable risk ap-
proach to determine the proportion of the total gap that
is due to within-country disparities in U5MR involved
three steps. The first is estimating the size of the global
gap. The second consists of preparing an alternative esti-
mate, to show how large the gap would be if mortality
inequalities within developing countries were eliminated
in the manner described below – that is, by improving
health among low- and middle-income groups to the
levels already enjoyed by the highest ones within the
countries concerned. The third and final step involves
comparing the estimates prepared in steps one and two.
The estimate prepared in the first step will be called
the “actual mortality gap” between developed and devel-
oping countries. It consists of the observed number of
under-five deaths in developing countries, minus the
number of such deaths were all economic groups in
those countries to enjoy the same U5MR as the average
found in developed countries. We calculated the ob-
served number of under-five deaths in developing coun-
tries by using country population, crude birth rate, and
U5MR in 2007 for all 67 countries included in the
analysis. The country population, crude birth rate, and
U5MR were taken from the World Development Indica-
tors (Additional file 1: Table S2) [15]. Then using the
same data, we calculated the number of under-five
deaths that would be observed had each of the 67 coun-
tries experienced the U5MR of developed countries in
2007 (7 per 1000 live births) [15]. The actual mortality
gap is the difference between the observed under-five
deaths and the estimated number of deaths using the de-
veloped countries’ U5MR in 2007.
The second estimate will be termed the “reduced mor-
tality gap” between these same two groups of countries.
It is the observed number of under-five deaths in devel-
oping countries, minus the number of such deaths were
the U5MR for each developing country to equal the
mortality rate experienced by the country's top eco-
nomic group. Using the pooled data of the 67 countries,
we computed U5MR for the top economic group (top
decile, ventile, and quintile) using appropriate weights as
described above.
We then applied the U5MR of the top economic
group to the total number of births in 2007 in the 67
countries to estimate the number of under-five deaths.
The “reduced mortality gap” is the difference betweenthe observed number of under-five deaths in these 67
developing countries in 2007 and the estimated number
of deaths using the U5MR in the top economic group in
the same 67 developing countries.
In the third step, the estimates produced in the first
and second steps are compared. The outcome expressed
in relative terms represents the percentage decrease in
the actual mortality gap that would result from achieving
the reduced gap just described. We used Stata version
12.0 for the analysis.Results
The list of 67 DHS datasets used and summary of the
data can be found in Additional file 1: Table S2. These
data covered approximately 4.2 million representatively-
selected individuals (after adjusting for sample weights),
and approximately one million births and 90,000 under-
five deaths during the ten years prior to each surveys. In
these countries, around 83.8 million births and 6.6 mil-
lion under-five deaths were recorded in 2007, the me-
dian year of the DHS surveys included in the analysis.
This 6.6 million represents about 72% of the 9.2 million
under-five deaths occurring in developing countries that
year [17].
The gap analysis results using the top 10% (decile) of
the population based on the wealth index as the top eco-
nomic group are presented in Table 1. It has three sec-
tions. Section A represents step one and the estimate
produced by it (actual mortality gap). Section B covers
the procedure’s second step, and the estimate that it
yields (reduced mortality gap). In Section C, the magni-
tudes of the two are compared.
Lines 1 and 2 of Table 1, Section A are taken from
Additional file 1: Table S2; they show the total number of
births and under-five deaths in the 67 countries covered.
Line 3 shows the number of under-five deaths that would
have occurred in these 67 countries had the births on line
1 been subject to the U5MR of 7 per 1,000 live births that
prevailed in developed countries in 2007. The difference
between lines 2 and 3, which appears on line 4, represents
the number of under-five deaths that would have been
averted in the 67 countries covered if their U5MR had
been that of the developed countries rather than their ac-
tual U5MR.
In Section B, the same analysis is repeated, only now
using the U5MR of 44.1 deaths per 1000 live births, the
mortality rate experienced in the top economic decile of
the included 67 developing countries. Line 7 represents
the number of under-five deaths that would have oc-
curred in the 67 countries had their average U5MR been
44.1 deaths per 1000 live births. (The U5MR of each
wealth decile, as well as of each wealth ventile and quintile,
appears in Additional file 1: Table S3a-c.). The reduced
Table 1 Impact of eliminating mortality disparities within
developing countries, by lowering mortality rates to
those enjoyed by the highest economic decile within
those countries: 67 low- and middle-income
countries, 2007
Section A. Actual mortality gap
1. Number of births (from Additional file 1: Table S2) 83,849,024
2. Number of under-5 deaths (from Additional file 1: Table S2) 6,555,200
3. No. of deaths at developed countries’ Rate (line 1 × .007)* 586,943
4. Actual mortality gap (line 2 – line 3) 5,968,257
Section B. Reduced mortality gap
5. Number of births (from Additional file 1: Table S2) 83,849,024
6. Number of under-5 deaths (from Additional file 1: Table S2) 6,555,200
7. No. of deaths at rate of countries’ best-off group (line 5 ×
top decile rate of 0.0441 deaths per live birth**)
3,697,742
8. Reduced mortality gap (line 6 – line 7) 2,857,458
Section C. Reduction in actual mortality gap by achieving reduced
mortality gap
9. Reduced mortality gap (from line 8) 2,857,458
10. Actual mortality gap (from line 4) 5,968,257
11. Percent reduction in actual gap by achieving reduced
gap (line 9 ÷ line 10)
47.9%
*The World Bank, World Development Indicators, 2012 (Washington, D.C.: The
World Bank, 2012).
http://data.worldbank.org/data-catalog/world-development-indicators.
**The mortality rate was not rounded for the calculation, so the value Line 7
differs slightly from Line 5 × 0.0441 (the rounded mortality rate).
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seven, and is reported on line eight.
The third and final step of the procedure, shown in
Section C, produces the outcome of interest. This out-
come comes from dividing the size of the reduced gap
(2,857,458, on line 9) by the actual gap (5,968,257 on
line 10). The result is 48%, indicating that the actual glo-
bal mortality gap could be reduced by 48% if the U5MR
in all economic groups in developing country popula-
tions could be lowered to that of the top 10% in those
populations. As can be seen from line 8 of the table, this
would result in around 2.9 million fewer under-five
deaths.
The analyses using mortality rates from the top wealth
quintile and ventile are available in Additional file 1:
Table S4a and b. The mortality gap would be reduced by
38% and 57% respectively.
Discussion
Using a population attributable risk approach, we dem-
onstrated that about half of the under-five mortality gap
between developed and developing countries can be re-
duced by lowering U5MR in each developing country to
the level enjoyed by the top economic stratum of these
countries. For our purposes, these developing countrieswere represented by the 67 countries with available DHS
data. An accurate appreciation of the findings’ implica-
tions requires a clear awareness of the many nuances in
the approach taken and the data used. In the present
case, three of the nuances are especially noteworthy.
First, the size of the intra-country mortality gap inevit-
ably depends upon how the best-off group is defined,
and there is no known conceptually-satisfying definition
for such a group. For example, it is likely that there ex-
ists within even the poorest countries some very small
but highly privileged groups with mortality rates close to
or even better than those of the industrialized world.
Were this small group to be taken as the best-off for the
purposes of the calculations performed here, then almost
all of the global mortality gap would be attributable to
differences within countries. Using lower economic cut-
offs (e.g. everyone above the poverty line) would produce
a higher U5MR among the reference population we are
using as “best off,” and a correspondingly lower portion
of the global gap resulting from intra-country disparities.
While the top wealth decile that we used in our ana-
lysis has served as the indicator of choice whenever the
available datasets are adequately large, it is largely arbi-
trary. Plausible alternatives exist, and their use could
produce notably different results. For example, using the
top 5% of the population as the reference group would
increase the relative difference between the two gap
measures from 48% to 57%, and the absolute difference
from 2.9 million to 3.4 million under-five deaths. Had
the reference group been the population’s top 20%, the
gap reported would have fallen to 38% and 2.3 million
under-five deaths. Such variability argues for considering
the results produced based on a 10% figure as no more
than a general sense of the magnitudes involved. It would
be safer to say, for example, that eliminating U5MR dis-
parities within developing countries by reducing U5MR
among developing countries could reasonably be expected
to reduce the actual global mortality gap by roughly a half,
and avert two to three million under-five deaths.
Second, while the population attributable risk ap-
proach used here is quite standard, it also represents no
more than a very schematic approximation of reality. In
actuality, it is obviously unrealistic to expect a sudden
decline in under-five mortality that would leave other
important parameters unchanged. Far more likely would
be an extended process of change, involving a wide
range of broad social and economic developments, as
well as health service modifications, shifting the relative
economic positions of different groups, and influencing
fertility as well as mortality. Whether such a process
might lead to results similar to those reported here is
difficult to say. The analysis presented does not however
make any assumption or claims about the determinants
or causes of mortality change.
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1994 and 2011 and the mortality rates computed re-
ferred to a period ten years preceding each survey. The
range in survey years introduces variability in the data. It
should be noted that our analysis utilizes estimates that
are averages over this period.
Findings in our study suggest that the global under-
five mortality gap could be reduced by roughly half by
eliminating intra-country U5MR disparities by economic
status, and doing so could avert around two to three
million deaths annually. The findings presented cannot
plausibly be viewed as providing more than general or-
ders of magnitude. However, our findings support two
principal points: that economic inequalities with respect
to health within developing countries contribute much
more to the global health gap than might appear to be
the case at first glance and that these inequalities de-
serve at least as much attention as does the gap between
those countries and developed countries.
Conclusion
Over six million more under-five deaths occur in devel-
oping countries than in developed countries every year.
Under-five mortality disparities within developing coun-
tries account for roughly half of that mortality gap.
Within-country inequities require as much consideration
as do inequities between the world’s developing and de-
veloped regions.
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